Biosecurity panel's findings heading to Obama

Friday, Oct 16, 2009 @ 1:59am by BioPrepWatch Reports

Read More »

UPMC, GE Healthcare create rapid-response manufacturing facility

Friday, Oct 16, 2009 @ 1:56am by BioPrepWatch Reports

Read More »

European Commission hopes to see action plan adopted by year end

Friday, Oct 16, 2009 @ 1:53am by BioPrepWatch Reports

The European Commission hopes its CBRN action plan, designed to improve the EU
Read More »

Roundtable discusses Europe's biopreparedness awareness

Friday, Oct 16, 2009 @ 1:46am by BioPrepWatch Reports

Read More »

Emergent BioSolutions recognized as best security organization

Monday, Sep 14, 2009 @ 11:16pm by BioPrepWatch Reports

LANSING, Mich -- Security magazine has named Emergent BioSolutions to its "Security 500: The Biggest and Best Security Organizations." This is first time the magazine has honored Emergent.
Read More »

New York prepares response to anthrax attack

Monday, Sep 14, 2009 @ 11:09pm by BioPrepWatch Reports

Read More »

Lieberman laments state of preparedness

Monday, Sep 14, 2009 @ 11:05pm by BioPrepWatch Reports

Sen. Joseph Lieberman (I-Conn.) is chairman of the Senate Homeland Security Committee. He spoke to BioTerrorWatch about the need to make the United States safer from the threat of weapons of mass destruction.
Read More »

Emergent BioSolutions submits development plan for anthrax vaccine

Monday, Sep 14, 2009 @ 11:02pm by BioPrepWatch Reports

ROCKVILLE, Md -- Emergent BioSolutions Inc. has submitted a development plan to the FDA for its Recombinant Protective Antigen (rPA) anthrax vaccine candidate.
Read More »

It can happen here, and it pays to be ready

Monday, Sep 14, 2009 @ 10:59pm by BioPrepWatch Reports

Read More »

Researcher proposes public-private partnership in war on terror

Monday, Sep 14, 2009 @ 10:50pm by BioPrepWatch Reports

Jeffrey A. Romoff spoke to BioTerrorWatch about his plan to improve the nation's capacity to develop and manufacture countermeasures critical to national and homeland security.
Read More »

DOR BioPharma awarded $500,000 for clinical study

Monday, Sep 14, 2009 @ 10:43pm by BioPrepWatch Reports

PRINCETON, N.J. -- The NIH has awarded DOR BioPharma a $500,000 Small Business Innovation Research grant to support a clinical evlauat
Read More »

Two-day training session simulates pneumonic plague attack

Monday, Sep 14, 2009 @ 10:38pm by BioPrepWatch Reports

Read More »